AMGN Amgen Inc.
Healthcare$335.94-0.99%ClosedMarket Cap: $181.31B
As of 2026-05-26
Valuation
P/E (TTM)
24.54
PEG
0.28
P/B
19.94
P/S
4.92
EV/EBITDA
13.17
DCF Value
$1,001.58
FCF Yield
4.7%
Div Yield
2.9%
Margins & Returns
Gross Margin
71.5%
Operating Margin
31.6%
Net Margin
20.9%
ROE
89.4%
ROA
8.4%
ROIC
13.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $8.62B | 68.2% | $2.67B | $1.82B | $— | $2.52 |
| Q4 null | $9.90B | 81.9% | $3.94B | $1.33B | $— | $2.38 |
| FY null | $36.74B | 70.8% | $10.68B | $7.71B | $— | $9.52 |
| Q3 null | $9.56B | 67.8% | $2.53B | $3.22B | $— | $2.38 |
| Q2 null | $9.17B | 67.2% | $2.64B | $1.43B | $— | $2.38 |
| Q1 null | $8.15B | 63.6% | $1.18B | $1.73B | $— | $2.38 |
| Q4 null | $9.09B | 65.7% | $2.31B | $627.0M | $— | $2.25 |
| FY null | $33.42B | 61.5% | $7.26B | $4.09B | $— | $9.00 |
| Q3 null | $8.50B | 61.1% | $2.05B | $2.83B | $— | $2.25 |
| Q2 null | $8.39B | 61.4% | $1.91B | $746.0M | $— | $2.25 |
| Q1 null | $7.45B | 57.0% | $991.0M | $-113.0M | $— | $2.25 |
| Q4 2023 | $8.20B | 62.0% | $1.27B | $767.0M | $1.42 | $2.13 |